FCBT
GSK icon

First Citizens Bank & Trust’s GSK GSK Stock Holding History

First Citizens Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,842
Closed -$267K – 660
2026
Q1 		$267K Sell
4,842
-363
-7% -$19.7K 0.01% 574
2025
Q4 		$255K Buy
+5,205
New +$243K 0.01% 584
2022
Q3 		– Sell
-4,023
Closed -$219K – 345
2022
Q2 		$219K Buy
4,023
+61
+2% +$3.37K 0.01% 362
2022
Q1 		$215K Buy
3,962
+312
+9% +$16.9K 0.01% 396
2021
Q4 		$201K Buy
+3,650
New +$190K 0.01% 420
2020
Q3 		– Sell
-7,154
Closed -$364K – 393
2020
Q2 		$364K Sell
7,154
-495
-6% -$25.4K 0.03% 232
2020
Q1 		$362K Buy
7,649
+706
+10% +$37.7K 0.04% 215
2019
Q4 		$408K Buy
6,943
+1,596
+30% +$88.8K 0.04% 227
2019
Q3 		$285K Buy
+5,347
New +$275K 0.03% 265
2018
Q3 		– Sell
-4,182
Closed -$211K – 431
2018
Q2 		$211K Buy
+4,182
New +$211K 0.03% 407
2015
Q4 		– Sell
-10,464
Closed -$503K – 387
2015
Q3 		$503K Sell
10,464
-1,623
-13% -$84.5K 0.04% 296
2015
Q2 		$629K Buy
+12,087
New +$681K 0.04% 297

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return

First Citizens Bank & Trust's GSK Position: Q2 2026 in Review

First Citizens Bank & Trust sold out of GSK (GSK) in Q2 2026, closing a stake of 4,842 shares — an estimated $267K sold.

First Citizens Bank & Trust first reported a position in GSK in Q2 2015 and held it in 12 quarters. The position peaked at $629K in Q2 2015. 195 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • First Citizens Bank & Trust reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • First Citizens Bank & Trust sold 4,842 GSK shares in Q2 2026, an estimated $267K.
  • First Citizens Bank & Trust first reported a position in GSK in Q2 2015 and held it in 12 quarters.
  • First Citizens Bank & Trust's GSK position peaked at $629K in Q2 2015.
  • 195 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.